Parliament Website

Pharmaceutical Pricing Regulation Scheme

EDM number 364 in 2015-16, proposed by Greg Mulholland on 21/07/2015.
Categorised under the topics of Health finance, Health services and Medicine.

That this House notes the Pharmaceutical Pricing Regulation Scheme (PPRS), a voluntary scheme where drugs companies pay a rebate to the Department of Health when NHS spending on branded medicines goes above agreed growth rates; further notes that the PPRS payment estimate for the UK in 2014-15 is £443 million and in 2015-16 is £995 million, of which the revised estimates of PPRS payments subsequently allocated to NHS England are £363 million and £796 million for those years respectively; shares industry concern that it is not clear where exactly these funds go once they have been allocated to the devolved health administrations; believes rebates from drugs companies should be properly accounted for and be used for spending on drugs; and therefore calls on the Department of Health to ringfence PPRS payments specifically to pay for drugs, in order to ensure patients elsewhere in the UK can also get access to much-needed treatments as soon as possible.

This motion has been signed by a total of 11 MPs.

Greg Mulholland21/07/2015Leeds North WestLiberal DemocratProposed
Mark Durkan07/09/2015FoyleSocial Democratic and Labour PartySeconded
Jim Shannon07/09/2015StrangfordDUPSeconded
Margaret Ritchie08/09/2015South DownSocial Democratic and Labour PartySeconded
David Simpson09/09/2015Upper BannDUPSeconded
Jeremy Corbyn10/09/2015Islington NorthLabourSeconded
Jim Cunningham10/09/2015Coventry SouthLabourSigned
Roger Godsiff11/09/2015Birmingham, Hall GreenLabourSigned
Rachael Maskell14/09/2015York CentralLabour/Co-operativeSigned
Paul Flynn15/09/2015Newport WestLabourSigned
Yasmin Qureshi26/10/2015Bolton South EastLabourSigned

Download raw data as csv or xml.